hyperCORE International Appoints New Executive Leadership Team

What Happened

Clinical research platform hyperCORE International has announced a new slate of officers to oversee its business operations. Jeffrey Smyth takes over as President, supported by Seneca Harrison as Vice President and Claxton Copeland as Secretary, with Dustin Owen remaining in his role as Treasurer.

The leadership shift aligns with the organization's dual-purpose model. The platform aims to assist clinical research site networks in scaling their operations while retaining their individual autonomy.

For Contract Research Organizations (CROs), the company functions as a centralized gateway to a broad network of research facilities. This structure is designed to simplify study feasibility and patient recruitment processes.

The Core Points

Jeffrey Smyth appointed as new President
Leadership team includes roles for VP, Secretary, and Treasurer
Focus on scaling site networks while maintaining independence
Provides CROs with a single point of contact for research sites
Network includes over 50 sites and access to 3.4 million patients

Context in 60 Seconds

The clinical trial landscape is increasingly moving toward consolidated networks to manage the complexities of modern drug development. By pooling resources and patient access, site networks can remain competitive against larger, integrated health systems without losing the specialized expertise of smaller, independent facilities.

CROs are also seeking more efficient ways to identify qualified research sites, leading to a demand for platforms that offer centralized management and rapid turnaround for trial feasibility. This transition reflects a broader shift toward streamlined operational partnerships in the life sciences sector.

Bottom Line

The new leadership team aims to solidify hyperCORE’s role as a bridge between independent research networks and CROs, emphasizing operational efficiency and sustainable growth.

Loading briefing details...